Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome

Arnau Vich Vila, Floris Imhann, Valerie Collij, Soesma A Jankipersadsing, Thomas Gurry, Zlatan Mujagic, Alexander Kurilshikov, Marc Jan Bonder, Xiaofang Jiang, Ettje F Tigchelaar, Jackie Dekens, Vera Peters, Michiel D Voskuil, Marijn C Visschedijk, Hendrik M van Dullemen, Daniel Keszthelyi, Morris A Swertz, Lude Franke, Rudi Alberts, Eleonora A M FestenGerard Dijkstra, Ad A M Masclee, Marten H Hofker, Ramnik J Xavier, Eric J Alm, Jingyuan Fu, Cisca Wijmenga, Daisy M A E Jonkers, Alexandra Zhernakova, Rinse K Weersma

OnderzoeksoutputAcademicpeer review

226 Citaten (Scopus)


Changes in the gut microbiota have been associated with two of the most common gastrointestinal diseases, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Here, we performed a case-control analysis using shotgun metagenomic sequencing of stool samples from 1792 individuals with IBD and IBS compared with control individuals in the general population. Despite substantial overlap between the gut microbiome of patients with IBD and IBS compared with control individuals, we were able to use gut microbiota composition differences to distinguish patients with IBD from those with IBS. By combining species-level profiles and strain-level profiles with bacterial growth rates, metabolic functions, antibiotic resistance, and virulence factor analyses, we identified key bacterial species that may be involved in two common gastrointestinal diseases.

Originele taal-2English
Aantal pagina's12
TijdschriftScience Translational Medicine
Nummer van het tijdschrift472
StatusPublished - 19-dec.-2018

Citeer dit